T Liang, Y Zhang, S Wu, Q Chen, L Wang - Frontiers in Pharmacology, 2022 - frontiersin.org
… and downstream signaling pathways of the NLRP3 inflammasome, as well as the latest
developments regarding its potential targets and therapeutic strategies for AD treatment. …